skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

6 Total results for product and free and sample content found

Scrip

From Solanezumab To Solithromycin: What To Watch For In Q4

11 Oct 2016

Lilly’s solanezumab, Roche/Genentech’s Ocrevus and Cempra’s solithromycin are among the key therapies scheduled for major data read-outs or approval decisions in Q4 2016.

Topics Clinical trial optimization

Scrip

Merck's Keytruda Chemo-Combo Data Has Big Implications For Future Of Immuno-Oncology

By Jessica Merril 10 Oct 2016

Merck’s strong Phase II data testing Keytruda with chemotherapy

Topics Immuno-oncology

Medtech Insight

Brexit where do notified body, authorized representative offices need to be?

By Amanda Maxwell 10 Oct 2016

Medtech regulatory service providers cannot afford to "wait and see" on the final outcome of Brexit. Questions such as the appropriate base of operations to serve device companies looking to

Topics Brexit

Scrip

Profile GSK's Mature Products Head Says Innovation Still Possible In Established Drugs Business

26 Sep 2016

Seasoned generics and intellectual property expert Richard Saynor went from poacher to game keeper

Topics Deal trends

Medtech Insight

From small republics big ideas grow

By Tina Tan 30 Aug 2016

In a bid to expand the talent pool in its burgeoning medtech sector, Singapore has looked to the US West Coast – long regarded as a leading innovation hub in the global medtech arena – for

Topics Medtech

Medtech Insight

At the intersection of quality and metrics: what's head In FDA’s effort to more objectively measure quality

By Shawn Schmitt 13 Jul 2016

Quality metrics are being developed by the US FDA to not only determine which medical device facilities to inspect next, but to also raise firms' overall approach to quality above baseline.

Topics Drug approval

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: